Abstract：Objective: To investigate the intervention of curcumin and its analogue J7 on oxidative stress injury in testis of type 2 diabetic rats. Methods: Sixty male SD rats, 10 rats were chosen as normal control group (NC), the other 50 rats were assigned to experiment group. Experiment diabetic rats were induced by high-fat food and intraperitoneal injection of steptozotocin (STZ). After the model was established successfully, diabetic rats were divided into four groups randomly: diabetes mellitus group (DM, n=12), curcumin treatment group (CUR, n=10), high dose treatment group of J7 (J+, n=10), low dose treatment group of J7 (J-, n=10). The CUR group were intragastrically administered with curcumin 20 mg/kg daily, in addition, the J+ group and the J- group were intragastrically administered with J7 20 mg/kg and 10 mg/kg daily respectively. After 8 weeks, the fast blood glucose was detected biochemically. The activity of superoxide dismutase (SOD) and the level of malondialdehyde (MDA) were detected by hydroxylamine method and thiobarbituric acid method respectively. The protein expressions of the nuclear factor-erythroid 2-related factor 2 (tNrf2), phosphorylation of Nrf2 (pNrf2), catalase (CAT), NAD(P)H quinine oxidoreductase 1 (NQO1) were measured by Western blot. The mRNA expressions of CAT, NQO1, hemeoxygenase-1 (HO1) were measured by quantitative real-time PCR (qRT-PCR). Morphological structure of testis was observed by hematoxylin-eosin (HE) staining. The expressions of Nrf2 and CAT were also detected by immunohistochemical method. Results: The levels of fast blood glucose and MDA in DM group were increased significantly(P＜0.05), while the body weight, the activity of SOD, the protein expressions of pNrf2/tNrf2, CAT, NQO1 and the mRNA expressions of CAT, NQO1, HO1 were decreased (P＜0.05). Under light microscope, the DM group showed disrupted histological appearance. Immunohistochemistry showed that the protein expressions of Nrf2 around the nucleus and CAT were decreased. With the treatment of curcumin and J7, the MDA levels in the three treatment groups were decreased (P＜0.05). The activity of SOD, the protein expressions of pNrf2/tNrf2, CAT, NQO1 and the mRNA expressions of NQO1, HO1 were increased (P＜0.05). the levels of fast blood glucose were decreased in the J+ and J- group (P＜0.05), and the mRNA expression of CAT was increased in the J+ group (P＜0.05). The ratio of pNrf2/tNrf2 in the J+ group was significantly higher than that in CUR and J- group (P＜0.05). The protein level of CAT in the J+ group was also significantly higher than that in J- group (P＜0.05). There were no significant differences in other indexes among the three treatment groups. Under light microscope, the morphology was obviously improved in the three treatment groups. Immunohistochemistry showed that the protein expressions of Nrf2 around the nucleus and CAT were increased in the three treatment groups. It was suggested that high dose J7 had better antioxidant stress ability in testis of diabetic rats. Conclusion: Curcumin and J7 could inhibit the oxidative stress damage of testicular tissue in diabetic rats, which might be related with the activation of the Nrf2-ARE signaling pathway.
Amaral S, Oliveira PJ, Ramalho-Santos J. Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species[J]. Curr Diabetes Rev, 2008, 4(1): 46-54.
Mulholland J, Mallidis C, Agbaje I, et al. Male diabetes mellitus and assisted reproduction treatment outcome[J]. Reprod Biomed Online, 2011, 22(2): 215-219.
Wu H, Kong L, Tan Y, et al. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21[J]. Diabetologia, 2016, 59(7): 1558-1568.
Wang Y, Zhang Z, Guo W, et al. Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function[J]. Am J Physiol Endocrinol Metab, 2014, 307(1): E14-E23.
Xu M, Dai DZ, Zhang Q, et al. Upregulated NADPH oxidase contributes to diabetic testicular complication and is relieved by strontium fructose 1,6-diphosphate[J]. Exp Clin Endocrinol Diabetes, 2010, 118(7): 459-465.
Shehzad A, Ha T, Subhan F, et al. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases[J]. Eur J Nutr, 2011, 50(3): 151-161.
Hatcher H, Planalp R, Cho J, et al. Curcumin: from ancient medicine to current clinical trials[J]. Cell Mol Life Sci, 2008, 65(11): 1631-1652.
Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035[J]. Diabetes Res Clin Pract, 2014, 103(2): 137-149.
LaVignera S, Condorelli R, Vicari E, et al. Diabetes mellitus and sperm parameters[J]. J Androl, 2012, 33(2): 145-153.
Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction[J]. Curr Opin Obstet Gynecol, 2006, 18(3): 325-332.
Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant geneexpression[J]. Free Radic Biol Med, 2004, 36(10): 1199-1207.
Nakamura BN, Lawson G, Chan JY, et al. Knockout of the transcription factor Nrf2 disrupts spermatogenesis in an age-dependent manner[J]. Free Radic Biol Med, 2010, 49(9): 1368-1379.
Hegazy AM, El-Sayed EM, Ibrahim KS, et al. Dietary antioxidant for disease prevention corroborated by the Nrf2 pathway[J]. J Complement Integr Med, 2019.
Kuriakose MA, Ramdas K, Dey B, et al. A randomized double-blind placebo-controlled phase IIB trial of curcumin in oral leukoplakia[J]. Cancer Prev Res (Phila), 2016, 9(8): 683-691.
Blanco-Garcia E, Otero-Espinar FJ, Blanco-Mendez J, et al. Development and characterization of anti-inflammatory activity of curcumin-loaded biodegradable microspheres with potential use in intestinal inflammatory disorders[J]. Int J Pharm, 2017, 518(1-2): 86-104.
Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises[J]. Mol Pharm, 2007, 4(6): 807-818.